ethylisopropylamiloride has been researched along with Growth Disorders in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, SM | 1 |
| Schreiner, CM | 1 |
| Schultheis, PJ | 1 |
| Miller, ML | 1 |
| Evans, RL | 1 |
| Vorhees, CV | 1 |
| Shull, GE | 1 |
| Scott, WJ | 1 |
1 other study available for ethylisopropylamiloride and Growth Disorders
| Article | Year |
|---|---|
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures.
Topics: Amiloride; Animals; Ataxia; Base Sequence; Body Weight; Chimera; Crosses, Genetic; Death; Embryonic | 1999 |